Ketorolac + Lidocaine for Pain Relief During Hysteroscopy

Phase 1

Recruiting

Led By Charles Ascher-Walsh, MD

Research Sponsored by Icahn School of Medicine at Mount Sinai

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Must not have

Chronic liver disease

History of gastritis or gastric ulcer

Timeline

Screening 3 weeks

Treatment Varies

Follow Up during procedure (cervical dilation)

Summary

"This trial compared the pain relief effects of using a combination of ketorolac and lidocaine versus using just lidocaine during office hysteroscopies."

Who is the study for?

This trial is for individuals experiencing abnormal uterine bleeding who are undergoing office hysteroscopy, a procedure to look inside the uterus. Participants should meet certain health criteria not specified here.

What is being tested?

The study compares pain relief during hysteroscopy using two methods: one combines ketorolac (a pain reliever) with lidocaine (an anesthetic), and the other uses just lidocaine. It's a randomized trial, so participants are put into groups by chance.

What are the potential side effects?

Possible side effects may include discomfort at the injection site, allergic reactions to medications used, or inadequate pain control. Specific side effects of ketorolac can include stomach upset or bleeding.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I have a long-term liver condition.

Select...

I have had gastritis or a stomach ulcer in the past.

Select...

I have a history of unusual bleeding.

Select...

I have kidney problems.

Select...

I am allergic to ketorolac or NSAIDs.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ with paracervical block, during procedure, immediately after procedure, thirty minutes after the procedure

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~with paracervical block, during procedure, immediately after procedure, thirty minutes after the procedure

This trial's timeline: 3 weeks for screening, Varies for treatment, and with paracervical block, during procedure, immediately after procedure, thirty minutes after the procedure for reporting.